After recommendations from the state’s medical marijuana advisory board, Pennsylvania Health Secretary Rachel Levine on Monday approved the sale of Marijuana as dry leaf or plant form for patients with qualifying medical conditions.
Levine allowing access to marijuana as a plant in Pennsylvania is to provide “a lower-cost option to the concentrate forms that must be processed and may cost $200-$300 a month,” the Pittsburgh Post-Gazette reported.
The flower or the plant is believed to be more effective in treating some medical conditions. It also gives better dosage control than the concentrate forms.
The sale of marijuana in dry leaf form, in theory, will allow users to vaporize and inhale it.
In 2016 alone, U.S. federal experts said more than 42,000 have died because of opioid overdose. The death toll in Connecticut increased to 917, they said.